Trade Groups Should Encourage Supplement NDI Compliance – Fabricant
This article was originally published in The Tan Sheet
Executive Summary
NDI compliance is “taking a back seat to how people feel about the guidance,” FDA official Daniel Fabricant says. Industry leaders ask what more they can do to encourage NDI notification compliance, but also reiterate concerns about FDA’s draft guidance.
You may also be interested in...
Industry Pushes FDA For Narrower Policy On NDI Notifications
FDA's expectation for firms to file new dietary ingredient notifications for all supplements that contain new ingredients "is tantamount to a registration process," industry leaders argue.
FDA, Trade Groups Team Up To Bolster Enforcement On Tainted Supplements
FDA threatens to take "swift and strong" enforcement action without warning, including filing criminal charges, against manufacturers, suppliers and distributors of tainted supplements, according to a letter sent to industry Dec. 15.
Coalition Pushes Congress On OTC Purchases With Health Savings Accounts
The Health Choices Coalition sent letters urging House and Senate members to support legislation that would strike the health care reform law requirement that consumers obtain a prescription in order to purchase OTCs with a pre-tax savings account.